11.93
-0.28 (-2.29%)
Previous Close | 12.21 |
Open | 12.25 |
Volume | 1,022,126 |
Avg. Volume (3M) | 1,067,771 |
Market Cap | 3,381,832,960 |
Price / Earnings (TTM) | 74.56 |
Price / Earnings (Forward) | 20.20 |
Price / Sales | 2.93 |
Price / Book | 7.93 |
52 Weeks Range | |
Earnings Date | 30 Apr 2025 - 5 May 2025 |
Profit Margin | 4.03% |
Operating Margin (TTM) | 34.03% |
Diluted EPS (TTM) | 0.160 |
Quarterly Revenue Growth (YOY) | -6.50% |
Quarterly Earnings Growth (YOY) | -68.10% |
Total Debt/Equity (MRQ) | 580.53% |
Current Ratio (MRQ) | 2.75 |
Operating Cash Flow (TTM) | 224.16 M |
Levered Free Cash Flow (TTM) | 107.18 M |
Return on Assets (TTM) | 6.76% |
Return on Equity (TTM) | 10.46% |
Market Trend
Short Term | Medium Term | ||
Industry | Diagnostics & Research (US) | Bearish | Bearish |
Diagnostics & Research (Global) | Bearish | Bearish | |
Stock | Sotera Health Company | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | 1.0 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 2.0 |
Average | 0.25 |
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions. |
|
Sector | Healthcare |
Industry | Diagnostics & Research |
Investment Style | Small Core |
% Held by Insiders | 2.44% |
% Held by Institutions | 93.96% |
Ownership
Name | Date | Shares Held |
---|---|---|
Warburg Pincus Llc | 31 Dec 2024 | 73,822,952 |
Sachem Head Capital Management Lp | 31 Dec 2024 | 7,910,000 |
52 Weeks Range | ||
Price Target Range | ||
High | 13.00 (Piper Sandler, 8.97%) | Hold |
Median | 12.50 (4.78%) | |
Low | 12.00 (Barclays, 0.59%) | Buy |
Average | 12.50 (4.78%) | |
Total | 1 Buy, 1 Hold | |
Avg. Price @ Call | 10.74 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Piper Sandler | 23 Apr 2025 | 13.00 (8.97%) | Hold | 10.87 |
Barclays | 10 Apr 2025 | 12.00 (0.59%) | Buy | 10.60 |
28 Feb 2025 | 16.00 (34.12%) | Buy | 12.47 |
No data within this time range.
Date | Type | Details |
---|---|---|
01 May 2025 | Announcement | Sotera Health Reports First-Quarter 2025 Results |
17 Apr 2025 | Announcement | Sotera Health Announces First-Quarter 2025 Earnings Release Date |
04 Mar 2025 | Announcement | Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results |
27 Feb 2025 | Announcement | Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook |
18 Feb 2025 | Announcement | Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |